Published in Cancer Weekly, October 25th, 2011
This panel does not include urologists or oncologists, and no new research has been cited that would call for this drastic change in prostate cancer testing recommendations since the USPSTF...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.